Piper Sandler lowered the firm’s price target on Carlyle Group to $46 from $48 and keeps an Overweight rating on the shares. The analyst adjusted asset manager models ahead of the Q1 results to account for flow and market activity as well as realizations and fund closings. Realizations and deployment activity across the alternatives industry remained pressured in the quarter, and the trend should continue through the first half of the year given continued volatility, contends Piper.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CG:
- ICU teams with Linden Capital for Medtronic assets bid, Reuters reports
- Carlyle, Lone Star join Apollo for Arconic bid, Dealreporter says
- Thermo Fisher, Celltrion compete for Baxter’s biopharma unit, Reuters says
- Buyout titans weighing purchases from SVB loan book, FT reports
- Carlyle Group initiated with an Overweight at Barclays